Cancer Institute A national cancer institute
designated cancer center
Profile http://med.stanford.edu/profiles/cancer/researcher/Laura_Johnston/
Email this profile
Portrait View Larger

Laura Johnston

Academic Appointments

  • Associate Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center

Key Documents

Contact Information

  • Clinical Offices
    Blood and Marrow Transplant Clinic 875 Blake Wilbur Dr Clinic E Stanford, CA 94305
    Tel Work (650) 498-6000 Fax (650) 498-5030
  • Academic Offices
    Personal Information
    Email
    Not for medical emergencies or patient use

Bio

Clinical Focus

  • Cancer> Blood and Marrow Transplant
  • Cancer> Hematology
  • Blood and Marrow Transplantation
  • Hematology
  • Graft-Versus-Host Disease

Academic Appointments

Professional Education

Internship: UCSF Medical Center CA (1990)
Fellowship: UCSF Medical Center CA (1995)
Residency: UCSF Medical Center CA (1992)
Medical Education: University of Minnesota School of Medicine MN (1989)
BS: University of MN, Microbiology (1982)
MD: University of MN, Medicine (1989)

Research & Scholarship

Current Research and Scholarly Interests

I conduct and develop clinical research trials in allogeneic and autologous hematopoietic cell transplantation (HCT) for hematologic malignancies: acute myelogenous leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), chronic lymphocytic leukemia (CLL), myeloproliferative disease, non-Hodgkin lymphoma (NHL), Hodgkin disease, myelodysplasia and aplastic anemia.


A specific interest is graft versus host disease (GVHD), exploring prevention and treatment of acute and chronic GVHD via clinical trials. The objectives of the GVHD trials are to reduce the incidence of GVHD, successfully treat acute and chronic GVHD, identify modalities or agents with more tolerable toxicity profiles and ultimately improve morbidity and mortality of affected patients. To this end, I have established a chronic GVHD clinic within the Stanford BMT division which aids in prospectively identifiing appropriate patients for clinical trials. The chronic GVHD clinic allows comprehensive evaluation and treatment for allogeneic BMT patients with new or progressive CGVHD. Through a multidisciplinary approach with my interested colleagues, I hope to impact the formidable effects GVHD has on the quality of life of the post-allogeneic transplant patient.


Other interests include unrelated donor HCT exploring alternate preparative regimens or graft sources as well as HLA typing.

Teaching

Courses

2013-14

Publications

Publications

Publication tag cloud

Publication Topics

View All 23

Stanford Medicine Resources:

Footer Links: